Vaccine Stocks—Including Pfizer, Moderna, BioNTech And Novavax—Slide Amid Plummeting Demand

Who Is Potential Biden Primary Challenger Dean Phillips? Millionaire Former Gelato Exec Turned Congressman Would Be President’s Most Prominent OpponentStocks of Pfizer and other Covid vaccine makers like BioNTech and Moderna fell in premarket trading Monday after the company slashed its revenue forecasts last week, a change in fortune for the sector as demand for the pandemic-related products that propelled them to record profits last year plummets.

by 13% on Friday due to sliding demand for its Covid-19 products. Sales of the firm’s mRNA shot, produced jointly with BioNTech, and its antiviral drug Paxlovid helped it secure record profits last year but the firm hasits projections for Paxlovid by $7 billion and by around $2 billion for its Covid shots, which was greater than analystsit was launching a $3.5 billion cost-cutting program covering jobs and expenses as it prepares for the hit to its revenues.

Brasil Últimas Notícias, Brasil Manchetes

Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.

Top Wall Street analysts believe in the long-term potential of these stocksTipRanks’ analyst ranking service pinpoints Wall Street’s best-performing stocks, including Amazon and Meta.
Fonte: NBCLA - 🏆 319. / 59 Consulte Mais informação »

Top Wall Street analysts believe in the long-term potential of these stocksTipRanks’ analyst ranking service pinpoints Wall Street’s best-performing stocks, including Amazon and Meta.
Fonte: NBCDFW - 🏆 288. / 63 Consulte Mais informação »

Top Wall Street analysts believe in the long-term potential of these stocksTipRanks’ analyst ranking service pinpoints Wall Street’s best-performing stocks, including Amazon and Meta.
Fonte: NBCLA - 🏆 319. / 59 Consulte Mais informação »